«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
24. Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic
Review of Population-Based Studies.Hirsch L, Yang J, Bresee L, Jette N1, Patten S,
Pringsheim T. Drug Saf. 2017 Sep;40(9):771-781.
25. Μεταβολικές διαταραχές μετά την λήψη άτυπων αντιψυχωσικών φαρμάκων,
Χρήστος Θελερiτης MD, PhD, ΕΓΚΕΦΑΛΟΣ 53, 62-66, 201626. Atypical
Antipsychotic AgentsSarayu Vasan; Sara Abdijadid. UCLA - Kern MedicalLast
Update: October 9, 2017.
27. Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors Laura C.
Sullivan, William P. Clarke, and Kelly A. Berg Curr Pharm Des. 2015; 21(26): 3732–
3738.
28. Blood pressure reducing effects of piromelatine and melatonin in spontaneously
hypertensive rats.Huang L, Zhang C, Hou Y, Laudon M, She M, Yang S, Ding L,
Wang H, Wang Z, He P, Yin W. Eur Rev Med Pharmacol Sci. 2013
Sep;17(18):2449-56.
29. Effect of melatonin in reducing second-generation antipsychotic metabolic
effects: A double blind controlled clinical trial. Agahi M, Akasheh N, Ahmadvand A,
Akbari H, Izadpanah F. Diabetes Metab Syndr. 2018 Jan - Mar;12(1):9-15.
30. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin
receptor 2C.Lord CC, Wyler SC, Wan R, Castorena CM, Ahmed N, Mathew D, Lee
S, Liu C, Elmquist JK. J Clin Invest. 2017 Sep 1;127(9):3402-3406.
31.
Aripiprazole-induced
adverse
metabolic
alterations
in
polyI:C
neurodevelopmental model of schizophrenia in rats. Horska K, Ruda-Kucerova J,
Drazanova E, Karpisek M, Demlova R, Kasparek T, Kotolova H.
Neuropharmacology. 2017 Sep 1;123:148-158
32. Prevalence and associations of the metabolic syndrome among patients
prescribed clozapine.Ahmed M, Hussain I, O'Brien SM, Dineen B, Griffin D,
McDonald C. Ir J Med Sci. 2008 Sep;177(3):205-10.
33. Metabolic screening after the American Diabetes Association's consensus
statement on antipsychotic drugs and diabetes. Morrato EH, Newcomer JW, Kamat
S, Baser O, Harnett J, Cuffel B. Diabetes Care. 2009 Jun;32(6):1037-42.
34. Metabolic syndrome with the atypical antipsychotics.Pramyothin P1, Khaodhiar
L. Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):460-6.
35. The prevalence and mechanisms of metabolic syndrome in schizophrenia: a
review Evangelos Papanastasiou Ther Adv Psychopharmacol. 2013 Feb; 3(1): 33–
51.
36. Metabolic syndrome in schizophrenia Nidhi Malhotra, Sandeep Grover, Subho
Chakrabarti, and Parmanand Kulhara Indian J Psychol Med. 2013 Jul-Sep; 35(3):
227–240.